TCGA analysis has reported high mRNA expression level of PD-L1, a PD-1 ligand, and CTLA-4 in mesenchymal GBMs suggesting a correlation between these immune checkpoint proteins and severity of GBM [99]. The gene discussed is CD274; the disease is glioblastoma.